Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 3702605, 7 pages
https://doi.org/10.1155/2017/3702605
Research Article

Outcome of Critically Ill Patients with Testicular Cancer

1Department of Critical Care Medicine, Instituto Nacional de Cancerología, 14080 Mexico City, Mexico
2Department of Critical Care Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 14000 Mexico City, Mexico
3Department of Critical Care Medicine, Fundación Clínica Médica Sur, 14050 Mexico City, Mexico

Correspondence should be addressed to Silvio A. Ñamendys-Silva

Received 5 May 2017; Accepted 19 September 2017; Published 26 October 2017

Academic Editor: Christian Schwentner

Copyright © 2017 Silvio A. Ñamendys-Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. J. Motzer, N. Agarwal, C. Beard et al., “Testicular cancer,” Journal of the National Comprehensive Cancer Network, vol. 10, no. 4, pp. 502–535, 2012. View at Publisher · View at Google Scholar
  2. K.-P. Dieckmann, J. T. Hartmann, J. Classen, M. Diederichs, and U. Pichlmeier, “Is increased body mass index associated with the incidence of testicular germ cell cancer?” Journal of Cancer Research and Clinical Oncology, vol. 135, no. 5, pp. 731–738, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Kirch, F. Blot, K. Fizazi, B. Raynard, C. Theodore, and G. Nitenberg, “Acute respiratory distress syndrome after chemotherapy for lung metastases from non-seminomatous germ-cell tumors,” Supportive Care in Cancer, vol. 11, no. 9, pp. 575–580, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. G. M. Mead, “International germ cell consensus classification: a prognostic factor- based staging system for metastatic germ cell cancers,” Journal of Clinical Oncology, vol. 15, no. 2, pp. 594–603, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. M. M. Oken, R. H. Creech, and D. C. Tormey, “Toxicity and response criteria of the Eastern Cooperative Oncology Group,” American Journal of Clinical Oncology, vol. 5, no. 6, pp. 649–655, 1982. View at Publisher · View at Google Scholar
  6. W. A. Knaus, E. A. Draper, D. P. Wagner, and J. E. Zimmerman, “APACHE II: a severity of disease classification system,” Critical Care Medicine, vol. 13, no. 10, pp. 818–829, 1985. View at Publisher · View at Google Scholar · View at Scopus
  7. S. A. Namendys-Silva, M. A. Silva-Medina, G. M. Vásquez-Barahona et al., “Application of a modified sequential organ failure assessment score to critically ill patients,” Brazilian Journal of Medical and Biological Research, vol. 46, no. 2, pp. 186–193, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. S. A. Ñamendys-Silva, M. O. González-Herrera, J. Texcocano-Becerra, and A. Herrera-Gómez, “Clinical characteristics and outcomes of critically ill cancer patients with septic shock,” QJM: An International Journal of Medicine, vol. 104, no. 6, pp. 505–511, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Rajpert-De Meyts, K. A. McGlynn, K. Okamoto, M. A. S. Jewett, and C. Bokemeyer, “Testicular germ cell tumours,” The Lancet, vol. 387, no. 10029, pp. 1762–1774, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Abramson and B. Melton, “Leukocytosis: basics of clinical assessment,” American Family Physician, vol. 62, no. 9, pp. 2053–2060, 2000. View at Google Scholar · View at Scopus
  11. A. D. Shah, S. Thornley, S.-C. Chung, S. Denaxas, R. Jackson, and H. Hemingway, “White cell count in the normal range and short-term and long-term mortality: International comparisons of electronic health record cohorts in England and New Zealand,” BMJ Open, vol. 7, no. 2, Article ID e013100, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Shankar, J. J. Wang, E. Rochtchina, M. C. Yu, R. Kefford, and P. Mitchell, “Association between circulating white blood cell count and cancer mortality. A population-based cohort study,” JAMA Internal Medicine, vol. 166, no. 2, pp. 188–194, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. E. D'Erasmo, M. Acca, F. Saverio Celi et al., “A hospital survey of hypocalcemia and hypophosphatemia in malignancy,” TUMORI, vol. 77, no. 4, pp. 311–314, 1991. View at Google Scholar · View at Scopus
  14. S. K. Aberegg, “Ionized calcium in the ICU should it be measured and corrected?” CHEST, vol. 149, no. 3, pp. 846–855, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. J. R. Zivin, T. Gooley, R. A. Zager, and M. J. Ryan, “Hypocalcemia: A pervasive metabolic abnormality in the critically ill,” American Journal of Kidney Diseases, vol. 37, no. 4, pp. 689–698, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Soares, P. Caruso, E. Silva et al., “Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study,” Crit Care Med, vol. 38, pp. 9–15, 2010. View at Google Scholar
  17. B. Lamia, M.-F. Hellot, C. Girault et al., “Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU,” Intensive Care Medicine, vol. 32, no. 10, pp. 1560–1568, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. F. S. Taccone, A. A. Artigas, C. L. Sprung, R. Moreno, Y. Sakr, and J.-L. Vincent, “Characteristics and outcomes of cancer patients in European ICUs,” Critical Care, vol. 13, no. 1, article no. R15, 2009. View at Publisher · View at Google Scholar · View at Scopus